APA (7th ed.) Citation

Tappeiner, C., Mesquida, M., Adán, A., Anton, J., Ramanan, A. V., Carreno, E., . . . Heiligenhaus, A. (2016). Evidence for tocilizumab as a treatment option in refractory uveitis associated with juvenile idiopathic arthritis. The journal of rheumatology, 43(12), . https://doi.org/10.3899/jrheum.160231

Chicago Style (17th ed.) Citation

Tappeiner, Christoph, et al. "Evidence for Tocilizumab as a Treatment Option in Refractory Uveitis Associated with Juvenile Idiopathic Arthritis." The Journal of Rheumatology 43, no. 12 (2016). https://doi.org/10.3899/jrheum.160231.

MLA (9th ed.) Citation

Tappeiner, Christoph, et al. "Evidence for Tocilizumab as a Treatment Option in Refractory Uveitis Associated with Juvenile Idiopathic Arthritis." The Journal of Rheumatology, vol. 43, no. 12, 2016, https://doi.org/10.3899/jrheum.160231.